Skip to main content
Fig. 2 | BMC Bioinformatics

Fig. 2

From: MethPat: a tool for the analysis and visualisation of complex methylation patterns obtained by massively parallel sequencing

Fig. 2

Methpat visualisation of DNA methylation at the MEST imprinted region on a range of primary cells (CD34, CD45, CD19 and CD33) and tissue (Whole blood), model cancer cell lines (HeLA and MDA-MB-231-BAG) and a normal lymphoblast cell line (BRL). The methylation status of MEST, expected to be ~50 % was observed in all normal sample types. The cancer cell lines demonstrate methylated MEST. In addition, Methpat visualizes the epiallelic diversity of MEST in all these samples

Back to article page